43857-0515 NDC - OLIGO BIO IODINE (CHELIDONIUM MAJUS, SPONGIA TOSTA, IODIUM, LYCOPUS VIRGINICUS, GINKGO BILOBA, PINUS SYLVESTRIS, FUCUS VESICULOSUS, GERMANIUM SESQUIOXIDE, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), CYSTEINUM, MANGANESE GLUCONATE, ALPHA-KETOGLUTARICUM ACIDUM, CALCAREA CARBONICA, FERRUM IODATUM, FUMARICUM ACIDUM, KALI IODATUM, NATRUM OXALACETICUM, PULSATILLA (VULGARIS), ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, EUGENOL, FORMALINUM, LIDOCAINE, MERCURIUS SOLUBILIS, MOLYBDENUM METALLICUM, NICCOLUM METALLICUM,)

Drug Information

Product NDC: 43857-0515

Proprietary Name: Oligo Bio Iodine

Non Proprietary Name: Chelidonium Majus, Spongia Tosta, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (Suis), Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,

Active Ingredient(s):
  • 12 [hp_X]/mL ANEMONE PULSATILLA;
  • 3 [hp_X]/mL CHELIDONIUM MAJUS;
  • 12 [hp_X]/mL COPPER;
  • 9 [hp_X]/mL CYSTEINE;
  • 12 [hp_X]/mL EUGENOL;
  • 12 [hp_X]/mL FERROUS IODIDE;
  • 12 [hp_X]/mL FORMALDEHYDE;
  • 6 [hp_X]/mL FUCUS VESICULOSUS;
  • 12 [hp_X]/mL FUMARIC ACID;
  • 8 [hp_X]/mL GERMANIUM SESQUIOXIDE;
  • 6 [hp_X]/mL GINKGO;
  • 12 [hp_X]/mL GOLD;
  • 33 [hp_C]/mL HUMAN COXSACKIEVIRUS A2;
  • 33 [hp_C]/mL HUMAN COXSACKIEVIRUS A7;
  • 33 [hp_C]/mL HUMAN COXSACKIEVIRUS B1;
  • 33 [hp_C]/mL HUMAN COXSACKIEVIRUS B3;
  • 33 [hp_C]/mL HUMAN COXSACKIEVIRUS B4;
  • 4 [hp_X]/mL IODINE;
  • 12 [hp_X]/mL LIDOCAINE;
  • 4 [hp_X]/mL LYCOPUS VIRGINICUS;
  • 10 [hp_X]/mL MANGANESE GLUCONATE;
  • 12 [hp_X]/mL MERCURIUS SOLUBILIS;
  • 12 [hp_X]/mL MOLYBDENUM;
  • 30 [hp_X]/mL MUMPS VIRUS;
  • 12 [hp_X]/mL NICKEL;
  • 12 [hp_X]/mL OXOGLURIC ACID;
  • 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE;
  • 12 [hp_X]/mL PALLADIUM;
  • 6 [hp_X]/mL PINUS SYLVESTRIS LEAFY TWIG;
  • 12 [hp_X]/mL POTASSIUM IODIDE;
  • 12 [hp_X]/mL RUBELLA VIRUS;
  • 12 [hp_X]/mL SILVER;
  • 12 [hp_X]/mL SODIUM DIETHYL OXALACETATE;
  • 3 [hp_X]/mL SPONGIA OFFICINALIS SKELETON, ROASTED;
  • 8 [hp_X]/mL SUS SCROFA PITUITARY GLAND;
  • 8 [hp_X]/mL SUS SCROFA THYROID;
  • 12 [hp_X]/mL TIN;
  • 12 [hp_X]/mL TITANIUM;
  • 12 [hp_X]/mL ZINC


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Amide Local Anesthetic [EPC];
  • Amides [CS];
  • Antiarrhythmic [EPC];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Copper [CS];
  • Copper-containing Intrauterine Device [EPC];
  • Decreased Embryonic Implantation [PE];
  • Decreased Sperm Motility [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Inhibit Ovum Fertilization [PE];
  • Local Anesthesia [PE];
  • Magnetic Resonance Contrast Activity [MoA];
  • Paramagnetic Contrast Agent [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC]

Labeler Information

Labeler Name: BioActive Nutritional, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/27/2019
End Marketing Date:11/6/2024

Package Information

No. Package Code Package Description Billing Unit
143857-0515-160 mL in 1 BOTTLE, DROPPER (43857-0515-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0515The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEOligo Bio IodineThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEChelidonium Majus, Spongia Tosta, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (Suis), Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/27/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE11/6/2024This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEANEMONE PULSATILLA; CHELIDONIUM MAJUS; COPPER; CYSTEINE; EUGENOL; FERROUS IODIDE; FORMALDEHYDE; FUCUS VESICULOSUS; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4; IODINE; LIDOCAINE; LYCOPUS VIRGINICUS; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; MOLYBDENUM; MUMPS VIRUS; NICKEL; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PALLADIUM; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; RUBELLA VIRUS; SILVER; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TIN; TITANIUM; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 3; 12; 9; 12; 12; 12; 6; 12; 8; 6; 12; 33; 33; 33; 33; 33; 4; 12; 4; 10; 12; 12; 30; 12; 12; 12; 12; 6; 12; 12; 12; 12; 3; 8; 8; 12; 12; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023